fda compounding semaglutide enforcement news november 2025 Have patients been harmed by unsafe drug compounding? – Partnership for Safe Medicines Compounded Semaglutide & Tirzepatide 2025:

Weight loss occurs system-wide, not in selected areas, so facial fat is lost alongside abdominal, hip and thigh fat

It works by targeting the brains hypothalamus, altering hunger signals and enhancing feelings of fullness, which supports healthier eating habits and reduces overall calorie intake

This helps with weight loss

Tirzepatide: The Dual Agonist Tirzepatide is often referred to as the next generation GLP-1 because it targets two hormones : This dual mechanism seems to amplify its effects

An early human pilot trial reported that exenatide combined with nicotine replacement therapy improved smoking abstinence and reduced cravings

Instead, they typically include ingredients such as: Berberine : A plant compound with some evidence for blood sugar benefits when taken orally Green tea extract : Contains caffeine and catechins, claimed to boost metabolism Garcinia cambogia : Fruit extract with limited evidence for weight loss Various vitamins and minerals : Including chromium, which has weak evidence for appetite control These products are marketed with claims like supports natural GLP-1 production or GLP-1 alternative, positioning themselves as comparable to prescription medications without requiring injections